Lorlatinib Generic ALK ROS1 Inhibitor Tabs

Lorlatinib is a kinase inhibitor that goes after ALK and ROS1, those genes that are too active in a lot of lung cancer types. It’s for people with an ALK-positive metastatic NSCLC who’ve moved on from other ALK inhibitor treatments. You can get Lorlatinib in 25 mg or 100 mg tablet sizes, both with a film coating.

The usual dose for adults is 100 mg, and you can take it with or without eating. Each pack comes with 30 tablets. This kinase inhibitor messes with cancer cells’ growth and spread.

It’s a third-generation one for ALK and ROS1, which means it’s less likely to cause issues than older versions.